{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:46:15Z","timestamp":1790646375149,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC)","award":["018655"],"award-info":[{"award-number":["018655"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RO1NS066019"],"award-info":[{"award-number":["RO1NS066019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21MH104318"],"award-info":[{"award-number":["R21MH104318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000194","name":"Nova Scotia Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009836","name":"Huntington Society of Canada","doi-asserted-by":"publisher","award":["ROP-97185"],"award-info":[{"award-number":["ROP-97185"]}],"id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.neuint.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T02:56:24Z","timestamp":1524797784000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1"],"prefix":"10.1016","volume":"123","author":[{"given":"Robert B.","family":"Laprairie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine T.","family":"Petr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn D.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Denovan-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-1118","authenticated-orcid":false,"given":"Paul A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2018.04.015_bib1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/npp.2012.22","article-title":"Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB\u2082 receptors","volume":"37","author":"Aracil-Fern\u00e1ndez","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2018.04.015_bib2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2018.04.015_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cne.20737","article-title":"Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization","volume":"492","author":"Berger","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2018.04.015_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/187152710793361568","article-title":"Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders","volume":"9","author":"Bisogno","year":"2010","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuint.2018.04.015_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fnhum.2016.00317","article-title":"Corticostriatal dysfunction in Huntington's disease: the basics","volume":"10","author":"Bunner","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib6","first-page":"e62","article-title":"Efficient mapping of transgene integration sites and local structural changes in Cre transgenic mice using targeted locus amplification","volume":"45","author":"Cain-Hom","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuint.2018.04.015_bib7","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1007\/s00259-010-1574-2","article-title":"Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism","volume":"37","author":"Casteels","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.neuint.2018.04.015_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2018.04.015_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2018.04.015_bib11","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2018.04.015_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1523\/JNEUROSCI.1586-03.2004","article-title":"The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib13","doi-asserted-by":"crossref","first-page":"17597","DOI":"10.1074\/jbc.M111101200","article-title":"Dynamin is a minibrain kinase\/dual specificity Yak-1 related kinase 1A substrate","volume":"277","author":"Chen-Hwang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.04.015_bib14","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proceedings of the National Academy of Science USA"},{"key":"10.1016\/j.neuint.2018.04.015_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2018.04.015_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0306-4522(92)90316-T","article-title":"An [Na+ K+] coupled L-glutamate transporter purified from rat brain is located in glial cell processes","volume":"51","author":"Danbolt","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2018.04.015_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0169-328X(98)00042-4","article-title":"Acute administration of cocaine, but not amphetamine, increases the level of synaptotagmin IV mRNA in the dorsal striatum of rat","volume":"55","author":"Denovan-Wright","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuint.2018.04.015_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2018.04.015_bib19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00213-018-4848-1","article-title":"Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine","volume":"235","author":"Fischer","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2018.04.015_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2008.08.043","article-title":"A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)","volume":"157","author":"Furness","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2018.04.015_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.pharmthera.2006.12.003","article-title":"Conditional gene targeting in the mouse nervous system: insights into brain function and diseases","volume":"113","author":"Gaveriaux-Ruff","year":"2007","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.neuint.2018.04.015_bib22","first-page":"1","article-title":"Phosphodiesterase 10 inhibitors in clinical development for CNS disorders","author":"Geerts","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuint.2018.04.015_bib23","doi-asserted-by":"crossref","first-page":"18275","DOI":"10.1523\/JNEUROSCI.3305-11.2011","article-title":"Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria","volume":"31","author":"Genda","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mcn.2005.12.004","article-title":"Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation","volume":"31","author":"Gomez","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/jpet.116.237388","article-title":"TAK-063, a novel phosphodiesterase 10A inhibitor, protects from striatal neurodegeneration and ameliorates behavioral deficits in the R6\/2 mouse model of Huntington's disease","volume":"360","author":"Harada","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.04.015_bib26","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1074\/jbc.271.44.27715","article-title":"Brain glutamate transporter proteins form homomultimers","volume":"271","author":"Haugeto","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.04.015_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuron.2004.06.019","article-title":"Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model","volume":"43","author":"He","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2018.04.015_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2018.04.015_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041152","article-title":"Promoters are differentially sensitive to N-terminal mutant huntingtin-mediated transcriptional repression","volume":"7","author":"Hogel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2018.04.015_bib30","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1523\/JNEUROSCI.5347-11.2012","article-title":"The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS","volume":"32","author":"Holmseth","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib31","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","article-title":"Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A","volume":"20","author":"Hu","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2018.04.015_bib33","first-page":"1213","volume":"66","author":"Jackson","year":"2018","journal-title":"Regulation of mitochondrial dynamics in astrocytes: mechanisms, consequences, and unknowns"},{"key":"10.1016\/j.neuint.2018.04.015_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuint.2018.04.015_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.110.173294","article-title":"Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease","volume":"336","author":"Kleiman","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2018.04.015_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.104","article-title":"Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets","volume":"3","author":"Laprairie","year":"2015","journal-title":"Pharmacology Research and Perspectives"},{"key":"10.1016\/j.neuint.2018.04.015_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.12.008","article-title":"The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients","volume":"267","author":"Laprairie","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuint.2018.04.015_bib38","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1523\/JNEUROSCI.15-03-01835.1995","article-title":"Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations","volume":"15","author":"Lehre","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2018.04.015_bib40","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuint.2018.04.015_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/glia.20744","article-title":"Synaptic localization of GLT-1a in the rat somatic sensory cortex","volume":"57","author":"Melone","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neuint.2018.04.015_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fnana.2010.00151","article-title":"Cellular and synaptic localization of EAAT2a in human cerebral cortex","volume":"4","author":"Melone","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuint.2018.04.015_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","article-title":"Endocannabinoid-mediated retrograde modulation of synaptic transmission","volume":"29C","author":"Ohno-Shosaku","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuint.2018.04.015_bib44","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1523\/JNEUROSCI.20-08-02749.2000","article-title":"Isolation of current components and partial reaction cycles in the glial glutamate transporter EAAT2","volume":"20","author":"Otis","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib45","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2018.04.015_bib46","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2018.04.015_bib47","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/ejn.12202","article-title":"Decreased expression of GLT-1 in the R6\/2 model of Huntington's disease does not worsen disease progression","volume":"38","author":"Petr","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib48","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1523\/JNEUROSCI.4255-14.2015","article-title":"Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes","volume":"35","author":"Petr","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.015_bib49","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","article-title":"Striatal synaptic dysfunction and altered calcium regulation in Huntington disease","volume":"483","author":"Raymond","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2018.04.015_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gene.20183","article-title":"Synapsin I Cre transgene expression in male mice produces germline recombination in progeny","volume":"44","author":"Rempe","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.neuint.2018.04.015_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2016.04.010","article-title":"GLT-1: the elusive presynaptic glutamate transporter","volume":"98","author":"Rimmele","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2018.04.015_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2016.03.014","article-title":"Astroglial glutamate transporters coordinate excitatory signaling and brain energetics","volume":"98","author":"Robinson","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2018.04.015_bib501","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs inducespartial reversal of disease progression in R6\/1 Huntington's disease transgenicmice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuint.2018.04.015_bib53","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","article-title":"Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1","volume":"276","author":"Tanaka","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuint.2018.04.015_bib54","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/gbb.12398","article-title":"ASIC1A in neurons is critical for fear-related behaviors","volume":"16","author":"Taugher","year":"2017","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuint.2018.04.015_bib55","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jnr.21046","article-title":"Striatal specificity of gene expression dysregulation in Huntington's disease","volume":"84","author":"Thomas","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2018.04.015_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-9861(20000131)417:1<103::AID-CNE8>3.0.CO;2-L","article-title":"Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus","volume":"417","author":"Van Bockstaele","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2018.04.015_bib57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/1381612820666140826114744","article-title":"Emerging biology of PDE10A","volume":"21","author":"Wilson","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuint.2018.04.015_bib58","article-title":"Axon-terminals expressing EAAT2 (GLT-1; Slc1a2) are common in the forebrain and not limited to the hippocampus","author":"Zhou","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2018.04.015_bib59","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618301062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618301062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:44:41Z","timestamp":1759311881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018618301062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":60,"alternative-id":["S0197018618301062"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2018.04.015","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}